Cases & Deals

  • Home
  • Practices
  • AbbVie develops intellectual property strategies related to BOTOX®

Share

AbbVie develops intellectual property strategies related to BOTOX®

September 2025

Client(s) AbbVie Inc.

Jones Day provides strategic intellectual property counseling to AbbVie Inc. regarding its Clostridium botulinum neurotoxin portfolio, including BOTOX® (onabotulinumtoxinA).

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.